ArticleCardiovascular diabetology. Endocrinology reports2026
Decoding the lipid etiology of atherogenic index of plasma and gout: establishing the causal role of triglycerides through NHANES, Mendelian randomization, and network pharmacology.
Article in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough a cross-sectional relation between the atherogenic index of plasma (AIP) and gout has been well documented, the causal roles of its principal components, TG and HDL-C, have not yet been clearly established. Therefore, this study sought to explicate the causal relations between AIP, its individual constituents, and the risk of gout, as well as to investigate the potential molecular mechanisms underlying these associations.
methodsWe adopted an integrated analytical pipeline. First, mediation and cross-sectional analyses were carried out to quantify the phenotypic associations of TG, HDL-C, and AIP with gout. Second, both multivariable and univariable Mendelian randomization (MR) analyses were applied to assess causal directions. Finally, a network pharmacology approach was applied to construct interaction networks linking lipid-related factors with gout, and subsequent enrichment analyses were done to identify the main biological pathways involved and key genes were identified using the Icelandic database's pQTLs.
resultsAIP showed a significant positive link with gout prevalence (OR = 1.700, p = 0.010), with this relationship being mediated mainly by HDL-C (45.19%), rather than TG or LDL-C. Univariable MR analyses indicated that TG exerted a substantial causal effect on gout risk (OR = 1.0058, p < 0.001). Although univariable MR showed a nominally protective association for HDLC (OR = 0.623, 95% CI: 0.399-0.974, p = 0.042), this effect was attenuated and became statistically nonsignificant after multivariable adjustment for other lipid traits (p > 0.05). After adjustment for genetic correlations in multivariable MR analyses, TG remained the sole lipid trait with a robust and independent causal effect on gout (OR = 1.0077, p < 0.001), whereas neither HDL-C nor LDL-C reached statistical significance. The TG-specific gout-associated gene set (Group B) was significantly enriched in T-cell receptor and NF-κB signaling pathways, with hub genes including PTPRC, MYD88, and LCK, supporting a direct lipid-immune axis. By contrast, the combined TG/HDL-C gene set (Group F) showed predominant enrichment in PI3K-Akt and cytokine-cytokine receptor pathways, whereas genes uniquely shared between HDL-C and gout (Group C) were mainly enriched in fundamental cellular processes without marked inflammatory pathway involvement.
conclusionsAIP exhibits a non-linear positive association with gout, but this association is primarily mediated by HDL‑C, which itself has no independent causal protective effect. TG may play an independent causal role in gout, potentially involving T‑cell receptor/NF‑κB signaling pathways. However, these findings are exploratory and require further validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.